
Autolus Therapeutics plc ADR (AUTL) Stock: A Guide to the Market Trend
The stock of Autolus Therapeutics plc ADR (AUTL) has gone down by -2.22% for the week, with a 11.86% rise in the past month and
The stock of Autolus Therapeutics plc ADR (AUTL) has gone down by -2.22% for the week, with a 11.86% rise in the past month and
The stock of Autolus Therapeutics plc ADR (AUTL) has seen a -16.93% decrease in the past week, with a -19.93% drop in the past month,
In the past week, AUTL stock has gone up by 17.91%, with a monthly decline of -7.06% and a quarterly plunge of -27.85%. The volatility
Moreover, the 36-month beta value for AUTL is 1.83. Analysts have varying opinions on the stock, with 8 analysts rating it as a “buy,” 2
Autolus Therapeutics plc ADR (NASDAQ: AUTL)’s stock price has soared by 1.27 in relation to previous closing price of 1.18. Nevertheless, the company has seen
Autolus Therapeutics plc ADR (NASDAQ: AUTL)’s stock price has plunge by -9.03relation to previous closing price of 1.55. Nevertheless, the company has seen a -12.96%
Autolus Therapeutics plc ADR (NASDAQ: AUTL) has seen a decline in its stock price by -0.25 in relation to its previous close of 1.62. However,
The stock of Autolus Therapeutics plc ADR (AUTL) has seen a -2.02% decrease in the past week, with a -4.43% drop in the past month,
© 2024, Powered by Smart TechOne
This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.
Strictly Necessary Cookie should be enabled at all times so that we can save your preferences for cookie settings.
If you disable this cookie, we will not be able to save your preferences. This means that every time you visit this website you will need to enable or disable cookies again.